LDLR and atherosclerosis: IL-27-deficient (Ldlr−/−Ebi3−/−) and IL-27 receptor-deficient (Ldlr−/−WSX-1−/−) Ldlr−/− knockout mice were more susceptible to develop atherosclerosis, and IL-27 administration suppressed macrophage activation and atherosclerosis development [23].